NEW YORK, September 23, 2015 /PRNewswire/ --

ACI Association has initiated research coverage on the following equities: American Capital Agency Corp.  (NASDAQ: AGNC), Apollo Investment Corporation (NASDAQ: AINV), American Capital, Ltd. (NASDAQ: ACAS), Amgen Inc. (NASDAQ: AMGN), Biogen Inc. (NASDAQ: BIIB). On Tuesday, September 22, 2015, NASDAQ ended at 4,756.72 down 1.50%, DOW declined 1.09%, to finish the day at 16,330.47, and the S&P closed at 1,942.74, down 1.23%. Register for your complimentary reports at the links given below.    

--

American Capital Agency Corp  

--

American Capital Agency Corp's stock edged lower by 1.32% to close Tuesday's session at USD 19.46. The company's shares oscillated between USD 19.45 and USD 19.67. The stock recorded a trading volume of 2.45 million shares, which was below its 50-day daily average volume of 3.51 million shares. Over the last three days, American Capital Agency Corp's shares have advanced 0.08% and in the past one week it has moved up 2.26%. On a compounded total return basis, the company has returned 0.66% in the past one month, and 1.33% in the past three months. American Capital Agency Corp has a current dividend yield of 12.17%. Further, the company is trading at a price to earnings ratio of 64.87 and at a price to book ratio of 0.81. Sign up and read the free notes on AGNC at:  http://www.aciassociation.com/AGNC.pdf

--

Apollo Investment Corp 

--

The stock of Apollo Investment Corp lost 1.02% to close Tuesday's session at USD 5.85. A trading volume of 2.31 million shares was recorded, which was greater than its 150-day daily average volume of 1.46 million shares. Over the last five days, Apollo Investment Corp's shares have declined by 7.44% and in the past one month, it has lost 9.86%. The stock has shown a negative return of 17.35% in the last three months, on a compounded total return basis. Apollo Investment Corp has a current dividend yield of 13.54%. The company is trading at a price to earnings ratio of 83.57, compared to a historical PE ratio of 22.54. Further, the stock is at a price to book ratio of 0.73, while the historical PB ratio is near to 0.94. Register for free on Equity Research Institute and access the latest research on AINV at:  http://www.aciassociation.com/AINV.pdf

--

American Capital Ltd  

--

American Capital Ltd's stock decreased by 1.24% to close Tuesday's session at USD 12.74. A total of 2.23 million shares exchanged hands, which surpassed its 50-day daily average volume of 1.68 million shares. Over the last three days American Capital Ltd's shares have declined by 2.00% and in the past one week it has moved down 2.52%. The stock has shown a negative return of 9.06% in the past three months, on a compounded total return basis. Further, the company is trading at a price to earnings ratio of 15.54, compared to a historical PE ratio of 9.45. The stock is at a price to book ratio of 0.63, while the historical PB ratio is near to 0.71. Additionally, the stock is trading at a price to cash flow ratio of 19.38 and price to sales ratio of 11.15. The complete research on ACAS is available for free at:  http://www.aciassociation.com/ACAS.pdf

--

Amgen Inc  

--

Amgen Inc's stock slipped by 0.79% to close Tuesday's session at USD 145.93. The company's shares oscillated between USD 142.82 and USD 146.78. The stock recorded a trading volume of 4.52 million shares, which was above its 50-day daily average volume of 3.93 million shares. Over the last three days, Amgen Inc's shares have declined by 5.18% and in the past one week, it has lost 4.08%. The stock has shown a negative return of 5.97% in the past one month, on a compounded total return basis. Further, the company is trading at a price to earnings ratio of 19.33, compared to a historical PE ratio of 23.78. The stock is at a price to book ratio of 4.03, while the historical PB ratio is near to 4.70. Free in-depth research on AMGN is available at:  http://www.aciassociation.com/AMGN.pdf

--

Biogen Inc  

--

Biogen Inc's stock advanced 0.64% to close Tuesday's session at USD 299.06. The stock recorded a trading volume of 4.39 million shares, which was above its 50-day daily average volume of 2.95 million shares. Over the last three days Biogen Inc's shares have declined by 8.07% and in the past one week it has moved down 6.50%. On a compounded total return basis, the stock has returned 1.16% in the past one month, but has shown a negative return of 28.38% in the past three months. The company is trading at a price to earnings ratio of 20.23, compared to a historical PE ratio of 27.43. Further, the stock is at a price to book ratio of 5.59, while the historical PB ratio is near to 7.37. Additionally, the stock is trading at a price to cash flow ratio of 17.02. The complimentary notes on BIIB can be downloaded in PDF format at:  http://www.aciassociation.com/BIIB.pdf

--

About ACI Association: 

Active Charter Investors Association ("ACI Association") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. ACI Association has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

ACI Association has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:  

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the Sponsor have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the Sponsor (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.  

NO WARRANTY 

ACI Association, the Author, the Reviewer and the Sponsor (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither ACI Association nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.aciassociation.com/.

RESTRICTIONS 

ACI Association is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


SOURCE www.aciassociation.com

Copyright 2015 PR Newswire

AGNC Investment (NASDAQ:AGNC)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more AGNC Investment Charts.
AGNC Investment (NASDAQ:AGNC)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more AGNC Investment Charts.